Indian Journal of Surgery

, Volume 77, Supplement 2, pp 314–318 | Cite as

The Factors Effecting Lymphovascular Invasion in Adenocarcinoma of the Colon and Rectum

  • Ali AktekinEmail author
  • Selvinaz Özkara
  • Günay Gürleyik
  • Mehmet Odabaşi
  • Tolga Müftüoğlu
  • Abdullah Sağlam
Original Article


Adenocarcinomas of the colon and rectum are the most common gastrointestinal malignancy, and lymph node metastases are established as a prognostic factor. Lymphovascular invasion has been recognized as an indication of lymph node metastases. This prompted us to investigate the features of primary tumor that may serve as a risk factor for lymphovascular invasion in colorectal carcinoma. Clinical and pathologic tissue data of colorectal carcinoma treated in our hospital were retrieved from the computer files at Haydarpasa Numune Education and Research Hospital, from June 1998 to December 2010, retrospectively. We excluded all patients who have two-thirds distal rectal carcinoma to rule out neoadjuvant treatment bias. Tissues from the specimens were stained with standard hematoxylin and eosin. Clinical data including age and sex of patient, location and diameter of tumor, perineural invasion, peritumoral lymphocytic infiltration, tumor grade, lymphovascular invasion, Pathologic T level (pT), and lymph node metastasis were recorded. Lymphovascular invasion was present only in 43 patients out of 108. Only pT and lymph node metastases were found to be statistically significant related to lymphovascular invasion (p = 0.04 and p < 0.001). Perineural invasion, pT, and peritumoral lymphocytic infiltration are the factors with p < 0.2 in the univariate analysis that were investigated with multivariate analysis, but no factor was found as an independent prognostic factor for lymphovascular invasion. Lymphovascular invasion is significantly related to lymph node metastases. Only pT is found as a factor that increases the lymphovascular invasion.


Colorectal adenocarcinoma Lymph node metastasis Lymphovascular invasion 


  1. 1.
    Jemal A, Murray T, Samuels A et al (2003) Cancer statistics, 2003. CA Cancer J Clin 53(1):5–26PubMedCrossRefGoogle Scholar
  2. 2.
    Wibe A, Syse A, Andersen E et al (2004) Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum 47(1):48–58PubMedCrossRefGoogle Scholar
  3. 3.
    Cecil TD, Sexton R, Moran BJ, Heald RJ (2004) Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum 47(7):1145–1150PubMedCrossRefGoogle Scholar
  4. 4.
    Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 28;1(8496):1479–1482Google Scholar
  5. 5.
    Brodsky JT, Richard GK, Cohen AM, Minsky BD (1992) Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer 15;69(2):322–326Google Scholar
  6. 6.
    Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124(7):979–994PubMedGoogle Scholar
  7. 7.
    Ross A, Rusnak C, Weinerman B et al (1999) Recurrence and survival after surgical management of rectal cancer. Am J Surg 177(5):392–395PubMedCrossRefGoogle Scholar
  8. 8.
    Koukourakis MI, Giatromanolaki A, Sivridis E, et al. (2005) Inclusion of vasculature-related variables in the Dukes staging system of colon cancer. Clin Cancer Res 15;11(24 Pt 1):8653–8660Google Scholar
  9. 9.
    Garcia-Aguilar J, Mellgren A, Sirivongs P et al (2000) Local excision of rectal cancer without adjuvant therapy: a word of caution. Ann Surg 231(3):345–351PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Lamont JP, McCarty TM, Digan RD et al (2000) Should locally excised T1 rectal cancer receive adjuvant chemoradiation? Am J Surg 180(6):402–406PubMedCrossRefGoogle Scholar
  11. 11.
    Meguerditchian AN, Bairati I, Lagacé R et al (2005) Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma. Am J Surg 189(6):707–713PubMedCrossRefGoogle Scholar
  12. 12.
    Nivatvongs S (2000) Surgical management of early colorectal cancer. World J Surg 24(9):1052–1055PubMedCrossRefGoogle Scholar
  13. 13.
    Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR (2002) Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 45(2):200–206PubMedCrossRefGoogle Scholar
  14. 14.
    Wang HS, Liang WY, Lin TC et al (2005) Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis. Dis Colon Rectum 48(6):1182–1192PubMedCrossRefGoogle Scholar
  15. 15.
    Tominaga K, Nakanishi Y, Nimura S et al (2005) Predictive histopathologic factors for lymph node metastasis in patients with nonpedunculated submucosal invasive colorectal carcinoma. Dis Colon Rectum 48(1):92–100PubMedCrossRefGoogle Scholar
  16. 16.
    Choi PW, Yu CS, Jang SJ et al (2008) Risk factors for lymph node metastasis in submucosal invasive colorectal cancer. World J Surg 32(9):2089–2094PubMedCrossRefGoogle Scholar
  17. 17.
    Lim SB, Yu CS, Jang SJ et al (2010) Prognostic significance of lymphovascular invasion in sporadic colorectal cancer. Dis Colon Rectum 53(4):377–384PubMedCrossRefGoogle Scholar
  18. 18.
    Walgenbach-Bruenagel G, Tolba RH, Varnai AD et al (2006) Detection of lymphatic invasion in early stage primary colorectal cancer with the monoclonal antibody D2-40. Eur Surg Res 38(5):438–444, Epub 2006 Aug 15PubMedCrossRefGoogle Scholar
  19. 19.
    Kingston EF, Goulding H, Bateman AC (2007) Vascular invasion is underrecognized in colorectal cancer using conventional hematoxylin and eosin staining. Dis Colon Rectum 50(11):1867–1872PubMedCrossRefGoogle Scholar
  20. 20.
    Fogt F, Zimmerman RL, Ross HM et al (2004) Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. Oncol Rep 11(1):47–50PubMedGoogle Scholar
  21. 21.
    Saad RS, Kordunsky L, Liu YL et al (2006) Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod Pathol 19(10):1317–1323PubMedCrossRefGoogle Scholar
  22. 22.
    Sternberg A, Amar M, Alfici R, Groisman G (2002) Conclusions from a study of venous invasion in stage IV colorectal adenocarcinoma. J Clin Pathol 55(1):17–21PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Janjan NA, Khoo VS, Abbruzzese J et al (1999) Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 15;44(5):1027–1038Google Scholar
  24. 24.
    Du CZ, Xue WC, Cai Y et al (2009) Lymphovascular invasion in rectal cancer following neoadjuvant radiotherapy: a retrospective cohort study. World J Gastroenterol 14;15(30):3793–3798Google Scholar
  25. 25.
    Cui Y, Yang H, Wu S et al (2002) Molecular mechanism of damage and repair of mouse thymus lymphocytes induced by radiation. Chin Med J (Engl) 115(7):1070–1073Google Scholar
  26. 26.
    Okabe S, Shia J, Nash G et al (2004) Lymph node metastasis in T1 adenocarcinoma of the colon and rectum. J Gastrointest Surg 8(8):1032–1040PubMedCrossRefGoogle Scholar
  27. 27.
    Son HJ, Song SY, Lee WY et al (2008) Characteristics of early colorectal carcinoma with lymph node metastatic disease. Hepatogastroenterology 55(85):1293–1297PubMedGoogle Scholar
  28. 28.
    Huh JW, Kim HR, Kim YJ (2010) Lymphovascular or perineural invasion may predict lymph node metastasis in patients with T1 and T2 colorectal cancer. J Gastrointest Surg 14(7):1074–1080PubMedCrossRefGoogle Scholar
  29. 29.
    Huh JW, Kim HR, Kim YJ (2010) Prognostic value of perineural invasion in patients with stage II colorectal cancer. Ann Surg Oncol 17(8):2066–2072PubMedCrossRefGoogle Scholar

Copyright information

© Association of Surgeons of India 2013

Authors and Affiliations

  • Ali Aktekin
    • 1
    Email author
  • Selvinaz Özkara
    • 2
  • Günay Gürleyik
    • 1
  • Mehmet Odabaşi
    • 1
  • Tolga Müftüoğlu
    • 1
  • Abdullah Sağlam
    • 1
  1. 1.4th General Surgery DepartmentHaydarpasa Numune Education and Research HospitalIstanbulTurkey
  2. 2.Pathology DepartmentHaydarpasa Numune Education and Research HospitalIstanbulTurkey

Personalised recommendations